Long pages

Showing below up to 50 results in range #42,021 to #42,070.

42021. (hist) Familywise error rate [4,828 bytes]
42022. (hist) Chromium(III) picolinate [4,828 bytes]
42023. (hist) GenMAPP [4,828 bytes]
42024. (hist) Lamivudine zidovudine clinical pharmacology [4,827 bytes]
42025. (hist) Clarithromycin dosage and administration [4,827 bytes]
42026. (hist) Spectinomycin warnings and precautions [4,827 bytes]
42027. (hist) Curry Tree [4,827 bytes]
42028. (hist) NHS Counter Fraud and Security Management Service [4,827 bytes]
42029. (hist) EHealth [4,827 bytes]
42030. (hist) Guanfacine (patient information) [4,827 bytes]
42031. (hist) Primary mediastinal large B-cell lymphoma classification [4,826 bytes]
42032. (hist) Cerebral venous sinus thrombosis (patient information) [4,826 bytes]
42033. (hist) Myocarditis (patient information) [4,826 bytes]
42034. (hist) Crigler-Najjar syndrome (patient information) [4,826 bytes]
42035. (hist) Intracoronary abciximab is superior to intravenous infusion in reducing infarct size during primary PCI [4,826 bytes]
42036. (hist) Parasitic worm [4,826 bytes]
42037. (hist) HOMER3 [4,825 bytes]
42038. (hist) Sandbox: hemorrhoids [4,825 bytes]
42039. (hist) Non small cell lung cancer management [4,825 bytes]
42040. (hist) Mitral stenosis epidemiology and demographics [4,825 bytes]
42041. (hist) Raynaud's disease (patient information) [4,825 bytes]
42042. (hist) BCAS2 [4,825 bytes]
42043. (hist) Elder law (United States) [4,825 bytes]
42044. (hist) Birthmark [4,825 bytes]
42045. (hist) Actinolite [4,825 bytes]
42046. (hist) Pterygium (patient information) [4,824 bytes]
42047. (hist) SPRR2A [4,824 bytes]
42048. (hist) The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Warfarin Polling Results for CLASS I Guidelines [4,824 bytes]
42049. (hist) Model [4,824 bytes]
42050. (hist) Sufentanil citrate injection (patient information) [4,824 bytes]
42051. (hist) Magnetosome [4,823 bytes]
42052. (hist) Ureter [4,823 bytes]
42053. (hist) STK38L [4,822 bytes]
42054. (hist) Glanzmann's thrombasthenia epidemiology and demographics [4,822 bytes]
42055. (hist) Chronic obstructive pulmonary disease future or investigational therapies [4,822 bytes]
42056. (hist) Lung cancer historical perspective [4,822 bytes]
42057. (hist) Mononuclidic elements [4,822 bytes]
42058. (hist) ORBIS International [4,822 bytes]
42059. (hist) RBM47 [4,821 bytes]
42060. (hist) HEYL [4,821 bytes]
42061. (hist) Esophageal stricture classification [4,821 bytes]
42062. (hist) Pulmonary hypertension risk factors [4,821 bytes]
42063. (hist) Poison ivy (patient information) [4,821 bytes]
42064. (hist) PCTK3 [4,821 bytes]
42065. (hist) Dioxygen difluoride [4,821 bytes]
42066. (hist) Frzb [4,821 bytes]
42067. (hist) RTN2 [4,820 bytes]
42068. (hist) SAV1 [4,820 bytes]
42069. (hist) Commotio cordis causes [4,820 bytes]
42070. (hist) The Living Guidelines: Patients with Cardiac Structural Abnormalities or Remodeling who have not Developed Heart Failure Symptoms. Suggest Revisions to the CLASS IIa Guidelines [4,820 bytes]